A Comparative Study Between Single vs Standard Two Doses of Basiliximab in Lung Transplantation

被引:0
|
作者
Logan, A. T. [1 ]
Qureshi, M. [2 ]
Martin, M. [3 ]
Zerdo, H. [4 ]
Patel, K. [2 ]
机构
[1] Tampa Gen Hosp, Pharm, Tampa, FL USA
[2] Univ S Florida, Tampa Gen Hosp, Tampa, FL USA
[3] Tampa Gen Hosp, USF Hlth, Taneja Coll Pharm, Tampa, FL USA
[4] Tampa Gen Hosp, Pharm, USF Hlth, Taneja Coll Pharm, Tampa, FL USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1400
引用
收藏
页码:S642 / S642
页数:1
相关论文
共 50 条
  • [1] Basiliximab:: A comparative study between the use of the recommended two doses versus a single dose in living donor kidney transplantation
    Baquero, A
    Pérez, J
    Rizik, N
    Lafontaine, H
    Carretero, V
    Suero, F
    Duran, F
    Polanco, M
    Figueroa, J
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (03) : 909 - 910
  • [2] Comparative study of basiliximab treatment in lung transplantation
    Borro, JM
    de la Torre, M
    Míguelez, C
    Fernandez, R
    Gonzalez, D
    Lemos, C
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3996 - 3998
  • [3] Basiliximab vs. limited-dose Daclizumab (2 mg/kg) administered in single or two separated doses in kidney transplantation
    Vega, Olynka
    Cardenas, Guillermo
    Correa-Rotter, Ricardo
    Alberu, Josefina
    Morales-Buenrostro, Luis E.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2008, 60 (02): : 82 - 86
  • [4] A comparative study of two infusion doses of etomidate for induction vs standard induction dose of etomidate
    Prakash, M. V. S. Satya
    Gnanasekar, Rajiv
    Sakthirajan, Panneerselvam
    Adole, Prashant S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (07) : 889 - 894
  • [5] A comparative study of two infusion doses of etomidate for induction vs standard induction dose of etomidate
    M. V. S. Satya Prakash
    Rajiv Gnanasekar
    Panneerselvam Sakthirajan
    Prashant S. Adole
    European Journal of Clinical Pharmacology, 2019, 75 : 889 - 894
  • [6] Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
    Furukawa, Masashi
    Chan, Ernest G.
    Ryan, John P.
    Hyzny, Eric J.
    Sacha, Lauren M.
    Coster, Jenalee N.
    Pilewski, Joseph M.
    Lendermon, Elizabeth A.
    Kilaru, Silpa D.
    McDyer, John F.
    Sanchez, Pablo G.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Outcomes in Single versus Standard Dose Basiliximab After Lung Transplant
    Shankar, S.
    Logan, A. T.
    Davis, N.
    Baker, L.
    Patel, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S124 - S125
  • [8] Y Basiliximab vs antithymocyte globulin after lung transplantation: A national review
    Mendes, Bruno de Aguiar
    Figueiredo, Carlos
    Cabral, Mariana
    Borba, Alexandra
    Mineiro, Alexandra
    Cardoso, Joao
    Calvinho, Paulo
    Semedo, Luisa
    Fragata, Jose
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] Comparative Efficacy And Side Effects Of Alemtuzumab Versus Basiliximab As Induction Agent In Lung Transplantation
    Kolman, D.
    Shapiro, W.
    Zhao, H.
    Butler-LeBair, M.
    Patel, N.
    Shiose, A.
    Toyoda, Y.
    Criner, G. J.
    Cordova, F. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [10] A COMPARATIVE-STUDY OF SINGLE AND MULTIPLE DOSES OF CLOBAZAM VS DIAZEPAM IN ANXIETY NEUROSIS
    DOONGAJI, DR
    SHETH, AS
    APTE, JS
    DESAI, AB
    VOHARA, SA
    DABHOLKAR, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (03): : 398 - 405